DUBLIN–(BUSINESS WIRE)–The “Marine Biotechnology – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.
A revised analysis puts the global market size at US$5.4 billion for the year 2027.
The COVID-19 induced recession has now cast serious questions on the ability of governments and companies to earmark financial commitments in times of crisis.
The only hope for the market in successfully mitigating the short- and long-term damage of the crisis is securing fiscal stimulus from governments. However, the commitment of pandemic scarred deficit widened governments in funding innovation ecosystems is yet to be seen.
Most R&D budgets, which are so vital for innovation, are largely dependent upon financial support from governments. Healthy financial performance of companies also determines the extent of willingness to reinvest earnings into R&D and new product development.
In the meantime, marine biotechnology research in all applications except healthcare will decline. While the economy is running out of money, biopharmaceutical research is landing big bucks as the world desperately seeks ways to treat, cure and stop the spread of the disease. Universities and top pharma industry R&D teams will continue to work together to address the pandemic. All hopes are pinned on biopharmaceutical innovation for a medical breakthrough to fight COVID-19.
Biopharmaceutical companies are witnessing their market cap rise significantly. (Read more…) The COVID tragedy will be the beginning of biotech revolution and innovation in treating diseases and developing vaccines. While the global economy slows down, pharma biotechnology firms both big and small will fearlessly continue to innovate and bring hope. This brings good news for healthcare applications of marine biotechnology. The potential to derive antiviral agents from marine fungi will be fully exploited now more than ever. Already, marine red algae are being researched for use as a coating material on surfaces & objects to curb the spread the disease & also in the production of antiviral drugs to fight COVID-19.
Another industry that has and will continue to witness the revolutionizing influence of marine biotechnology is the pharmaceutical industry. Pharma companies plunge into the seas in search of newer, safer, natural and more effective drugs. Marine organisms-derived chemicals have the advantage of abundance and can be easily produced in large scale. New discoveries and development of marine peptides will drive growth of peptide therapeutics in the coming years.
Bioactive marine compounds developed so far include Alkaloids, Lactones, Hydroxybenzene, Quinones, Peptides, Sterides, Aether, and Ketal. Marine-derived pharmaceuticals are already making an impact on therapeutic areas such as anti-cancer, anti-bacterial, anti-fungus, anti-virus, pest resistance, and pulmonary hypertensive vascular disease (PHVD), among others. Nutraceuticals, cosmetics and antibiotics will witness the biggest impact, followed by bioactives and bio-assays in clinical diagnostics.
With numerous pharmacological properties waiting to be exploited, there are strong investment opportunities for further research in this space. Environmental remediation also represents another interesting area of opportunity with new biotechnological approaches helping develop novel biosensing technologies, and anti-fouling technologies for protection and management of the environment.
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Impact of Covid-19 and a Looming Global Recession
- A Prelude to Marine Biotechnology
- Global Marine Biotechnology Market Set to Witness Rapid Growth
- Developed Regions Dominate, Developing to Witness Fastest Growth
- Biomaterials and Bio Active Substances Lead the Marine Biotechnology Market
- Drug-Discovery: A Promising Outcome of Marine Biotechnology
- Recent Market Activity
2. FOCUS ON SELECT PLAYERS
- Aker BioMarine AS (Norway)
- Aqua Bio Technology ASA (Norway)
- BASF SE (Germany)
- CP Kelco (USA)
- Cyanotech Corp. (USA)
- GlycoMar Ltd. (UK)
- Lonza Group Ltd. (Switzerland)
- Marinova Pty Ltd (Australia)
- New England Biolabs Inc (USA)
- NovaMatrix (Norway)
- Nutrex Hawaii Inc., (USA)
- oceanBASIS GmbH (Germany)
- PharmaMar S.A (Spain)
- Prolume Ltd (USA)
- BioLume, Inc. (USA)
- Royal DSM N.V (Netherlands)
- Sea Run Holdings, Inc. (USA)
- SEPPIC (France)
- Biotech Marine (France)
- Tequesta BioVentures (USA)
3. MARKET TRENDS & DRIVERS
- Industry Witnesses a Rise in Sea Farming Operations
- Data Science and Big Data Step In to Simplify Marine Biotech Processes
- Active Participation of Investors to Steer Marine Biotechnology Sector
- Focus on Biofuels as the Future Energy Security Solution Drives Strong Demand
- Innovative Technologies and Strategies Fuel Demand for Algal Fuel
- Microbial Fuel Cells (MFCs) : An Emerging Area of Interest
- Healthcare: A Fast Growing Avenue
- Select Marine Bio-Products Commercially Available
- Health-Promoting Benefits of Marine Algal Proteins
- Sea Anemone Toxins: Opportunities in the Pharma Sector
- Marine Worm: Potential Role in Medical Applications
- Biopharmaceutical Companies Shift Focus to Marine Natural Products
- Technology Advancements Aid Research Activities
- Research Focus Entrenched on Marine Drugs
- Select Marine Pharmaceutical Products – Development/Approval Status
- Robust Clinical Pipeline to Support Growth
- Anti-Cancer Drugs Dominate Drug Development Pipeline
- Cardiovascular Marine Products
- An Overview of Select Cardiovascular Marine Products
- Cardiovascular Marine Products by Marine Source
- Coral Reefs Offer Abundant Opportunities
- Rise in Application of Seaweeds
- Marine Microalgae: Promising Potential in Varied Industries
- Commercially Cultivated Marine Microalgae Species and their Applications
- Major Applications of Marine Microalgae Biomass or their Extracts
- Polysaccharides from Marine Microalgae Hold Significant Potential
- Select Marine Microalgae Species Producing Polysaccharides
- Carotenoids of Marine Origin Find Increased Application as Natural Colorants in Supplements and Foods
- Major Commercially Available Carotenoids
- Carotenoids of Marine Origin and Growing Opportunities in Cosmetics
- Select Carotenoids and their Functional Benefits in Nutricosmetics Market
- Research on Rise for Marine Ingredients for Bonding Applications
- Partnerships: Vital for Development of Marine Biotechnology Research
- Microalgae Biotechnology Set to Change Molecular Landscape of Agricultural and Industrial Practices
- Algae-based High-Value Products
- Growing Focus on Application in Bioplastics, Biopolymers and Bulk Chemicals
- Biodegradation of Various Emerging Contaminants using Algae
- R&D ACTIVITY IN MARINE BIOTECHNOLOGY – A REVIEW
- Overview
- R&D Initiatives, Programs & Research Priorities for Marine Biotechnology
- Entities Involved in Marine Biotechnology R&D in the US: A Snapshot
- A REVIEW OF END-USE MARKETS/APPLICATIONS
- Consumer Products
- Marine Biotechnology for Sustainable Production of Healthy Food Products
- Aquaculture
- Marine Resources as Functional Food Ingredients
- Health Benefits of Few Marine-derived Functional Food Ingredients
- Marine-Derived Nutraceuticals
- Major Marine Nutraceutical Products: A Glance
- Cosmetics: A Important Growth Market
- Focus Shifts to Sustainable Sourcing of Marine Ingredients in Cosmetics Industry
- Marine Biotechnology Application in Industrial Processing
- Marine Microbial Enzymes
- Marine-Derived Biopolymers & Biomaterials
- Marine Algae in Feed and Other Applications
- Chitin & Chitosan
- Marine Bacteria
- Extremozymes Hold an Edge
- Marine-Derived Pharmaceuticals
- Major Marine Sources for Drugs
- Applications of Marine Products in the Pharmaceutical Industry
- Key Challenges in Discovery of Marine-derived Drugs
- Marine Biotechnology for Energy Supply
- Marine Biotechnology for Protecting Marine Ecosystems
- Biofouling
- Detecting Marine Pathogenic Organisms
- Bioremediation Of Marine Ecosystems
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
- GEOGRAPHIC MARKET ANALYSIS
IV. COMPETITION
- Total Companies Profiled: 64
For more information about this report visit https://www.researchandmarkets.com/r/c0eet4
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900